Coronavirus
India to increase interval between doses of AstraZeneca shot
India’s health ministry on Monday wrote to states asking them to administer second AstraZeneca coronavirus vaccine doses to recipients within four to eight weeks, from the current guideline of four to six weeks.
For all the latest headlines follow our Google News channel online or via the app.
“The recommendation has been revised to provide the 2nd dose of COVISHIELD at 4-8 weeks’ interval after the 1st dose, instead of earlier practiced interval of 4-6 weeks,” the ministry said in a statement, using the brand name for the vaccine made locally by the Serum Institute of India.
Read more:
A year on from lockdown, India reports worst daily rise in COVID-19 in months
Asia accelerates AstraZeneca COVID-19 vaccine rollouts, as trust plunges in Europe
Taiwan kicks off inoculation drive with AstraZeneca COVID-19 jab
Also Read
-
India’s Serum Institute delays vaccine shipments to Brazil, Morocco, Saudi
The Serum Institute of India (SII) has told Brazil, Saudi Arabia and Morocco that further supplies of the AstraZeneca COVID-19 vaccine will be delayed ... Coronavirus -
India backs AstraZeneca COVID-19 vaccine as cases soar
India said on Wednesday its coronavirus immunization campaign would continue with “full rigor” despite some concerns in Europe about the safety of the ... Coronavirus -
India’s drug regulator eases norms for use of homegrown COVID-19 vaccine
An expert panel of India’s drug regulator has recommended relaxing norms for the use of a government-backed coronavirus vaccine after it was found to ... Coronavirus -
Pfizer seeks to make vaccine in India if assured of faster clearance, export freedom
Pfizer Inc has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance andfreedom on ... Coronavirus
